FDA, FTC Join Forces To Eliminate Barriers To Biosimilar Competition

 
• By Brenda Sandburg
  
Conceptual business illustration with the words anti-competitive practices
FDA and FTC to target anticompetitive behavior that impedes access to biosimilars
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics